Improving life for cancer patients through transformative drugs

Play

News

2018/06/18

Continued discussions with FDA on proposed remetinostat phase III design results in delay in planned start of study

Read more
2018/05/31

Phase I/II study design of birinapant in combination with Keytruda® to be presented on June 4 at the ASCO Annual Meeting

Read more
2018/05/18

Additional remetinostat phase II data will be presented at the International Investigative Dermatology meeting on May 18 and 19

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.